NCT04993209 - Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil | Biotech Hunter

Enrollment

320

Participants

Timeline

Start Date

July 9, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

November 4, 2022

Conditions

Coronavirus InfectionsHealthy

Interventions

BIOLOGICAL

NDV-HXP-S 1μg

NDV-HXP-S 1μg 0.5mL 2 doses intramuscular (deltoid) 28 days apart

BIOLOGICAL

NDV-HXP-S 3μg

NDV-HXP-S 3μg 0.5mL 2 doses intramuscular (deltoid) 28 days apart

BIOLOGICAL

NDV-HXP-S 10μg

NDV-HXP-S 10μg 0.5mL 2 doses intramuscular (deltoid) 28 days apart

OTHER

Adsorbed inactivated COVID-19 vaccine (CoronaVac)

Adsorbed inactivated COVID-19 vaccine 600 SU/0.5 mL 2 doses intramuscular (deltoid) 28 days apart

Trial Locations (1)

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto